The Dexamethasone Suppression Test and Prediction of Outcome in Patients Receiving ECT

1987 ◽  
Vol 150 (3) ◽  
pp. 315-318 ◽  
Author(s):  
C. L. E. Katona ◽  
C. R. Aldridge ◽  
Martin Roth ◽  
J. Hyde
Keyword(s):  
Electroconvulsive Therapy ◽  
Depressive Episode ◽  
Major Depressive Episode ◽  
Dexamethasone Suppression Test ◽  
Prediction Of Outcome ◽  
Major Depressive ◽  
Suppression Test ◽  
Dexamethasone Suppression

Twenty-six in-patients satisfying DSM-III criteria for major depressive episode were assessed using the Newcastle Diagnostic and ECT Predictor Scales and the dexamethasone suppression test (DST), prior to commencing a course of electroconvulsive therapy (ECT). The Newcastle ECT Predictor Scale was successful in predicting both immediate outcome and outcome over the 6 months following ECT; the DST was unsuccessful in predicting either immediate or 6-month outcome.

Major Depressive Episode and Low Dose Dexamethasone Suppression Test

1982 ◽  
Vol 36 (2) ◽  
pp. 109-114
Author(s):  
Masakazu Sarai ◽  
Norio Taniguchi ◽  
Takao Kagomoto ◽  
Hideaki Kameda ◽  
Takeshi Uema ◽  
...  
Keyword(s):  
Depressive Episode ◽  
Low Dose ◽  
Major Depressive Episode ◽  
Dexamethasone Suppression Test ◽  
Major Depressive ◽  
Suppression Test ◽  
Dexamethasone Suppression

Performance of the Dexamethasone Suppression Test in Depressive Illness According to ICD and DSM-III Classification Systems

1988 ◽  
Vol 152 (4) ◽  
pp. 554-558 ◽  
Author(s):  
Sarah Watkins ◽  
Brian Harris ◽  
Nigel Cook ◽  
Roger Thomas ◽  
Diana Riad-Fahmy
Keyword(s):  
Major Depressive Episode ◽  
Depressive Illness ◽  
Dexamethasone Suppression Test ◽  
Classification Systems ◽  
Manic Depressive Illness ◽  
Major Depressive ◽  
Diagnostic Categories ◽  
Manic Depressive ◽  
Suppression Test ◽  
Dexamethasone Suppression

The performance of the dexamethasone suppression test was assessed in 90 consecutive admissions with a diagnosis of depression, categorised according to two classification systems (DSM-III and ICD-9). Non-suppression was found in most of the diagnostic categories, but there was a highly significant association with the DSM-III classification ‘major depressive episode with melancholia’ (52%) in comparison with the ICD group ‘manic-depressive illness-depressed’ (29%).

Dexamethasone Suppression Test in Depression and other Psychiatric Illness

1983 ◽  
Vol 142 (5) ◽  
pp. 498-504 ◽  
Author(s):  
A. Coppen ◽  
M. Abou-Saleh ◽  
P. Milln ◽  
M. Metcalfe ◽  
J. Harwood ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Affective Disorders ◽  
Psychiatric Illness ◽  
Dexamethasone Suppression Test ◽  
Major Depressive ◽  
Abnormal Response ◽  
Suppression Test ◽  
Dexamethasone Suppression ◽  
Normal Controls

SummaryThe prevalence of an abnormal response to the dexamethasone suppression test (DST) was examined in 119 in-patients suffering from a major depressive disorder and in 79 normal controls. Only 11 per cent of controls showed an abnormal DST as against 70 per cent of depressed patients. The specificity of the DST was examined by testing patients with other psychiatric disorders. Abnormal responses were found in one-fifth of a sample of schizophrenics, over one-quarter of abstinent alcoholics, two-fifths of neurotics (including neurotic depressives) and almost half of senile dements. Abnormal DST was also found in 33 per cent of patients receiving prophylactic lithium for recurrent affective disorders.

scholarly journals The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode

2020 ◽  
Vol 13 (5) ◽  
pp. 1284-1295
Author(s):  
Harold A. Sackeim ◽  
Joan Prudic ◽  
D.P. Devanand ◽  
Mitchell S. Nobler ◽  
Roger F. Haskett ◽  
...  
Keyword(s):  
Electroconvulsive Therapy ◽  
Depressive Episode ◽  
Major Depressive Episode ◽  
Treatment Technique ◽  
Major Depressive ◽  
Benefits And Costs

Uses of Electroconvulsive Therapy in Conditions Other than Major Depressive Episode

2019 ◽  
Vol 49 (4) ◽  
pp. 157-163 ◽  
Author(s):  
Sandarsh Surya ◽  
Ram Bishnoi ◽  
Peter B. Rosenquist ◽  
William V. McCall
Keyword(s):  
Electroconvulsive Therapy ◽  
Depressive Episode ◽  
Major Depressive Episode ◽  
Major Depressive

Endocrine and behavioural responses to methylphenidate in depression

1986 ◽  
Vol 16 (3) ◽  
pp. 531-540 ◽  
Author(s):  
Peter R. Joyce ◽  
Richard A. Donald ◽  
M. Gary Nicholls ◽  
John H. Livesey ◽  
Robyn M. Abbott
Keyword(s):  
Growth Hormone ◽  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Dexamethasone Suppression Test ◽  
Cortisol Response ◽  
Major Depressive ◽  
Behavioural Responses ◽  
Baseline Cortisol ◽  
Suppression Test ◽  
Dexamethasone Suppression

SynopsisTwenty patients with a major depressive disorder and 20 control subjects were subjected to a 1 mg dexamethasone suppression test (DST) and a challenge with intravenous (IV) methylphenidate (MP)(0·3 mg/kg). None of the controls, but 9 depressives, were DST non-suppressors. Among the depressives there were correlations between DST-cortisol and baseline (4 p.m.) levels of cortisol, growth hormone, prolactin and adrenaline. Compared with the controls the depressives had a decreased cortisol response and an enhanced adrenaline response to the MP challenge. The decreased cortisol response was not related to either DST-cortisol or baseline cortisol, but was correlated with the mood response to MP.

Sign in / Sign up

Export Citation Format

Share Document